BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21946812)

  • 1. Improving the diagnostic yield from staging laparoscopy for periampullary malignancies: the value of preoperative inflammatory markers and radiological tumor size.
    Garcea G; Cairns V; Berry DP; Neal CP; Metcalfe MS; Dennison AR
    Pancreas; 2012 Mar; 41(2):233-7. PubMed ID: 21946812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and peri-ampullary cancer.
    Alexakis N; Gomatos IP; Sbarounis S; Toutouzas K; Katsaragakis S; Zografos G; Konstandoulakis MM
    Eur J Surg Oncol; 2015 Feb; 41(2):265-9. PubMed ID: 25266999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma.
    Karabicak I; Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Matsui Y; Kon M
    J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):750-755. PubMed ID: 27794194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer.
    Smith RA; Bosonnet L; Ghaneh P; Sutton R; Evans J; Healey P; Garvey C; Hughes M; Raraty M; Campbell F; Neoptolemos JP
    Surgery; 2008 May; 143(5):658-66. PubMed ID: 18436014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
    Maithel SK; Maloney S; Winston C; Gönen M; D'Angelica MI; Dematteo RP; Jarnagin WR; Brennan MF; Allen PJ
    Ann Surg Oncol; 2008 Dec; 15(12):3512-20. PubMed ID: 18781364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms.
    White R; Winston C; Gonen M; D'Angelica M; Jarnagin W; Fong Y; Conlon K; Brennan M; Allen P
    J Am Coll Surg; 2008 Mar; 206(3):445-50. PubMed ID: 18308214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative prediction of complete resection in pancreatic cancer.
    Shah D; Fisher WE; Hodges SE; Wu MF; Hilsenbeck SG; Charles Brunicardi F
    J Surg Res; 2008 Jun; 147(2):216-20. PubMed ID: 18498873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
    Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
    Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies.
    Friess H; Kleeff J; Silva JC; Sadowski C; Baer HU; Büchler MW
    J Am Coll Surg; 1998 Jun; 186(6):675-82. PubMed ID: 9632157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective use of staging laparoscopy based on carbohydrate antigen 19-9 level and tumor size in patients with radiographically defined potentially or borderline resectable pancreatic cancer.
    Satoi S; Yanagimoto H; Toyokawa H; Inoue K; Wada K; Yamamoto T; Hirooka S; Yamaki S; Yui R; Mergental H; Kwon AH
    Pancreas; 2011 Apr; 40(3):426-32. PubMed ID: 21206325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
    Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
    Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?
    Barreiro CJ; Lillemoe KD; Koniaris LG; Sohn TA; Yeo CJ; Coleman J; Fishman EK; Cameron JL
    J Gastrointest Surg; 2002; 6(1):75-81. PubMed ID: 11986021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with laparoscopic ultrasonography for defining tumour resectability in carcinoma of the pancreatic head and periampullary region.
    Taylor AM; Roberts SA; Manson JM
    Br J Surg; 2001 Aug; 88(8):1077-83. PubMed ID: 11488793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of diagnostic laparoscopy in periampullary and pancreatic cancers. A study based on 27 cases].
    Molnár G; Iancu C; Munteanu D; Muntean V; Al Hajjarz N; Bălă O; Vlad L
    Chirurgia (Bucur); 2010; 105(3):383-6. PubMed ID: 20726306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging with helical computed tomography and laparoscopy in pancreatic head cancer.
    Yoshida T; Matsumoto T; Morii Y; Ishio T; Kitano S; Yamada Y; Mori H
    Hepatogastroenterology; 2002; 49(47):1428-31. PubMed ID: 12239959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma.
    Ong SL; Garcea G; Thomasset SC; Mann CD; Neal CP; Abu Amara M; Dennison AR; Berry DP
    J Gastrointest Surg; 2008 Jun; 12(6):1068-73. PubMed ID: 18043987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy.
    Connor S; Bosonnet L; Alexakis N; Raraty M; Ghaneh P; Sutton R; Neoptolemos JP
    Dig Surg; 2005; 22(1-2):80-5. PubMed ID: 15849467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.